In a financing environment that calls for most new biotech companies’ operations to consist of only a briefcase and a BlackBerry, Forma Therapeutics is an outlier. Just a year old, the firm has taken on more than 85 employees, set up sparkling labs in the Science Hotel facility, in Cambridge, Mass., and put together an integrated drug discovery platform. With technology in chemistry and biology, the company believes it can build a pipeline . . .